首页 > 最新文献

Journal of Burn Care & Research最新文献

英文 中文
Prescription Analysis of Antihistamines' Use in Patients with Moderate to Severe Burns. 中重度烧伤患者抗组胺药的处方分析。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-23 DOI: 10.1093/jbcr/irag007
Abbas A Karim, Nizam Karim, Suhaib Shah, Rashid Syed, Zain Akbar, Farhad Marzook, Juquan Song, George Golovko, Steven E Wolf, Amina El Ayadi

Post-burn pruritus (PBP) significantly affects patients, causing discomfort and hindering recovery. Antihistamines, which block H1 receptors, are commonly prescribed for PBP, yet large-scale studies on their usage patterns are limited. This study evaluates antihistamine prescription trends and provider practices for PBP across varying burn severities from moderate to severe burns (≥20% TBSA). A treatment pathways analysis was performed using TriNetX, a global, federated, deidentified database. Patients with burns ≥20% TBSA from the past 20 years (2004-2024) who developed pruritus were identified and stratified into four cohorts: 20-40%, 40-60%, 60-80%, and ≥80% TBSA. The analysis evaluated trends in antihistamine prescriptions, including the number of patients treated with antihistamines, types prescribed, and median times to treatment initiation, duration, and therapy switching. The total sample included 2,754 patients (20-40% TBSA, n=1,712; 40-60%, n=613; 60-80%, n=253; ≥80%, n=176). Over 70% received antihistamines, with hydroxyzine as the most common first-line therapy, followed by diphenhydramine. Across all cohorts, the average of the median times for initiation, therapy duration, and time before switching was 16.75 days, 90.25 days, and 27.75 days, respectively. Significant variations in the timing of therapy initiation suggest a gap in consistent symptom management during critical recovery periods, potentially affecting patient comfort and overall outcomes. These findings underscore the importance of vigilant post-burn assessment, stepwise escalation based on response, and complementary strategies to optimize PBP management. Frequent switching and prolonged durations suggest a need for more effective and tailored therapeutic approaches to improve recovery outcomes for burn patients.

烧伤后瘙痒(PBP)严重影响患者,引起不适并阻碍康复。抗组胺药,阻断H1受体,通常用于PBP,但对其使用模式的大规模研究是有限的。本研究评估了中度至重度烧伤(≥20% TBSA)中抗组胺处方趋势和提供者治疗PBP的做法。使用TriNetX进行治疗途径分析,这是一个全球性的、联合的、未识别的数据库。过去20年(2004-2024年)烧伤≥20% TBSA并发瘙痒的患者被确定并分为4组:20-40%、40-60%、60-80%和≥80% TBSA。该分析评估了抗组胺药物处方的趋势,包括接受抗组胺药物治疗的患者人数、处方类型、开始治疗的中位时间、持续时间和治疗转换。共纳入2754例患者(TBSA 20-40%, n= 1712; 40-60%, n=613; 60-80%, n=253;≥80%,n=176)。超过70%的患者接受了抗组胺药治疗,羟嗪是最常见的一线治疗,其次是苯海拉明。在所有队列中,开始治疗、治疗持续时间和转换前的平均中位时间分别为16.75天、90.25天和27.75天。治疗开始时间的显著差异表明,在关键的恢复期间,一致的症状管理存在差距,可能影响患者的舒适度和总体结果。这些发现强调了警惕烧伤后评估、基于反应的逐步升级以及优化PBP管理的补充策略的重要性。频繁切换和持续时间延长表明需要更有效和量身定制的治疗方法来改善烧伤患者的恢复结果。
{"title":"Prescription Analysis of Antihistamines' Use in Patients with Moderate to Severe Burns.","authors":"Abbas A Karim, Nizam Karim, Suhaib Shah, Rashid Syed, Zain Akbar, Farhad Marzook, Juquan Song, George Golovko, Steven E Wolf, Amina El Ayadi","doi":"10.1093/jbcr/irag007","DOIUrl":"https://doi.org/10.1093/jbcr/irag007","url":null,"abstract":"<p><p>Post-burn pruritus (PBP) significantly affects patients, causing discomfort and hindering recovery. Antihistamines, which block H1 receptors, are commonly prescribed for PBP, yet large-scale studies on their usage patterns are limited. This study evaluates antihistamine prescription trends and provider practices for PBP across varying burn severities from moderate to severe burns (≥20% TBSA). A treatment pathways analysis was performed using TriNetX, a global, federated, deidentified database. Patients with burns ≥20% TBSA from the past 20 years (2004-2024) who developed pruritus were identified and stratified into four cohorts: 20-40%, 40-60%, 60-80%, and ≥80% TBSA. The analysis evaluated trends in antihistamine prescriptions, including the number of patients treated with antihistamines, types prescribed, and median times to treatment initiation, duration, and therapy switching. The total sample included 2,754 patients (20-40% TBSA, n=1,712; 40-60%, n=613; 60-80%, n=253; ≥80%, n=176). Over 70% received antihistamines, with hydroxyzine as the most common first-line therapy, followed by diphenhydramine. Across all cohorts, the average of the median times for initiation, therapy duration, and time before switching was 16.75 days, 90.25 days, and 27.75 days, respectively. Significant variations in the timing of therapy initiation suggest a gap in consistent symptom management during critical recovery periods, potentially affecting patient comfort and overall outcomes. These findings underscore the importance of vigilant post-burn assessment, stepwise escalation based on response, and complementary strategies to optimize PBP management. Frequent switching and prolonged durations suggest a need for more effective and tailored therapeutic approaches to improve recovery outcomes for burn patients.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nigella sativa and Its Bioactive Compound Thymoquinone in Burn Therapy: Mechanisms, Efficacy, and Safety. 黑草及其生物活性化合物百里醌在烧伤治疗中的作用:机制、疗效和安全性。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-23 DOI: 10.1093/jbcr/irag006
Sonali Karhana, Garzain Bint E Attar, Wala Alshammari, Mohd Ashif Khan

Burn injuries represent a worldwide public health concern. Nigella sativa (NS), a herbal medicinal plant, widely used in Ayurveda, Unani, and Siddha holds potential to address this issue. This review evaluated the potential of NS extract and its key component, Thymoquinone (TQ), in accelerating burn wound healing, focusing on their mechanisms, safety, and efficacy. Studies were retrieved from PubMed, Google Scholar, and ScienceDirect using keywords "Nigella sativa," "Thymoquinone," "burns," and "wound healing." Reports were screened for suitability, and the scientific name was verified on www.worldfloraonline.org. NS extract and TQ accelerate burn wound healing in vitro and in vivo through various mechanisms involving anti-inflammatory, anti-oxidative, anti-microbial, and tissue regenerative effects. TQ achieved 91.35% wound closure in NIH/3T3 cells (mouse fibroblasts) and wound closure rate of 2.35 ± 0.05% in 3T3-CCL92 cells (fibroblasts from mouse embryos). It also reduced oxidative stress and inflammation in murine burn models. Nanoformulations of TQ showed higher safety (LD₅₀: 300-2000 mg/kg) than pure TQ (LD₅₀: 50-300 mg/kg). A Phase I trial confirmed the safety of black cumin oil (5% TQ) at 200 mg/day for 90 days in healthy adults. Therefore, formulations based on NS extract and TQ can manage burn injuries and be extrapolated into clinical settings.

烧伤是一个世界性的公共卫生问题。Nigella sativa (NS)是一种草药植物,广泛用于阿育吠陀、乌纳尼和悉达,具有解决这一问题的潜力。本文综述了NS提取物及其关键成分百里醌(TQ)在促进烧伤创面愈合方面的潜力,重点讨论了其机制、安全性和有效性。研究从PubMed,谷歌Scholar和ScienceDirect检索,关键词是“黑草”,“百里醌”,“烧伤”和“伤口愈合”。对报告的适用性进行了筛选,并在www.worldfloraonline.org上验证了学名。NS提取物和TQ通过抗炎、抗氧化、抗微生物和组织再生等多种机制促进烧伤创面体外和体内愈合。TQ在NIH/3T3细胞(小鼠成纤维细胞)中的创面愈合率为91.35%,在3T3- ccl92细胞(小鼠胚胎成纤维细胞)中的创面愈合率为2.35±0.05%。它还能减少小鼠烧伤模型中的氧化应激和炎症。纳米配方的TQ显示出更高的安全性(LD₅₀:300-2000 mg/kg)比纯TQ (LD₅₀:50-300 mg/kg)。一项I期试验证实了黑孜然油(5% TQ)在健康成人中200毫克/天连续90天的安全性。因此,基于NS提取物和TQ的配方可以治疗烧伤,并可推广到临床环境中。
{"title":"Nigella sativa and Its Bioactive Compound Thymoquinone in Burn Therapy: Mechanisms, Efficacy, and Safety.","authors":"Sonali Karhana, Garzain Bint E Attar, Wala Alshammari, Mohd Ashif Khan","doi":"10.1093/jbcr/irag006","DOIUrl":"https://doi.org/10.1093/jbcr/irag006","url":null,"abstract":"<p><p>Burn injuries represent a worldwide public health concern. Nigella sativa (NS), a herbal medicinal plant, widely used in Ayurveda, Unani, and Siddha holds potential to address this issue. This review evaluated the potential of NS extract and its key component, Thymoquinone (TQ), in accelerating burn wound healing, focusing on their mechanisms, safety, and efficacy. Studies were retrieved from PubMed, Google Scholar, and ScienceDirect using keywords \"Nigella sativa,\" \"Thymoquinone,\" \"burns,\" and \"wound healing.\" Reports were screened for suitability, and the scientific name was verified on www.worldfloraonline.org. NS extract and TQ accelerate burn wound healing in vitro and in vivo through various mechanisms involving anti-inflammatory, anti-oxidative, anti-microbial, and tissue regenerative effects. TQ achieved 91.35% wound closure in NIH/3T3 cells (mouse fibroblasts) and wound closure rate of 2.35 ± 0.05% in 3T3-CCL92 cells (fibroblasts from mouse embryos). It also reduced oxidative stress and inflammation in murine burn models. Nanoformulations of TQ showed higher safety (LD₅₀: 300-2000 mg/kg) than pure TQ (LD₅₀: 50-300 mg/kg). A Phase I trial confirmed the safety of black cumin oil (5% TQ) at 200 mg/day for 90 days in healthy adults. Therefore, formulations based on NS extract and TQ can manage burn injuries and be extrapolated into clinical settings.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Changing Landscape of Pediatric Burns in the United Kingdom: A 20 Year Epidemiological Study. 儿童烧伤的变化景观在英国:20年的流行病学研究。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-23 DOI: 10.1093/jbcr/irag009
Lucy M S Hoade, Thomas H Jovic, Elliott N Rees, Zita M Jessop, Peter J Drew

Burns are a leading cause of childhood injury. Analysis of pediatric burn epidemiology is essential for targeting educational and public health strategies but there is limited available UK data, particularly traversing the COVID-19 pandemic. We hypothesize that the last 20 years have seen significant changes in injury patterns and service provision, with a marked effect from national lockdown measures. This study aims to describe the epidemiology of pediatric burns referrals and admissions within a pediatric burns unit in the UK over 20 years (2005-2024). A retrospective analysis was performed for pediatric patients referred to our center between 2005 and 2024. The International Burn Injury Database (iBID) was used to extract demographic and injury information. Data before, during and after COVID-19 lockdown periods was compared. 6919 patients met the inclusion criteria. 1872 (27.1%) of patients required admission. There was a significant reduction in admission rate following covid despite an increase in average TBSA (p<0.01). Most cases were scalds (n=3100, 44.8%) or contact burns (n=2650, 38.3%). The majority of patients were aged under 5 years (n=4529, 65.5%), with a rise in referrals for older children across the study period. There was a noticeable rise in aerosol-related flash burns, cold burns and treadmill- related friction burns during and after the pandemic. This study provides epidemiological data for the development of public health initiatives and adaptation of pediatric burns services. Emerging mechanistic trends and service re-design following the COVID pandemic requires further multi-center evaluation to inform future care.

烧伤是儿童受伤的主要原因。儿科烧伤流行病学分析对于制定教育和公共卫生战略至关重要,但英国的可用数据有限,特别是在2019冠状病毒病大流行期间。我们假设,在过去20年里,在国家封锁措施的显著影响下,伤害模式和服务提供发生了重大变化。本研究旨在描述20年来(2005-2024年)英国儿科烧伤部门儿科烧伤转诊和入院的流行病学。回顾性分析了2005年至2024年间到本中心就诊的儿科患者。使用国际烧伤数据库(iBID)提取人口统计和损伤信息。比较了COVID-19封锁期间之前、期间和之后的数据。6919例患者符合纳入标准。1872例(27.1%)患者需要住院。covid后入院率显着降低,尽管平均TBSA增加(p
{"title":"The Changing Landscape of Pediatric Burns in the United Kingdom: A 20 Year Epidemiological Study.","authors":"Lucy M S Hoade, Thomas H Jovic, Elliott N Rees, Zita M Jessop, Peter J Drew","doi":"10.1093/jbcr/irag009","DOIUrl":"https://doi.org/10.1093/jbcr/irag009","url":null,"abstract":"<p><p>Burns are a leading cause of childhood injury. Analysis of pediatric burn epidemiology is essential for targeting educational and public health strategies but there is limited available UK data, particularly traversing the COVID-19 pandemic. We hypothesize that the last 20 years have seen significant changes in injury patterns and service provision, with a marked effect from national lockdown measures. This study aims to describe the epidemiology of pediatric burns referrals and admissions within a pediatric burns unit in the UK over 20 years (2005-2024). A retrospective analysis was performed for pediatric patients referred to our center between 2005 and 2024. The International Burn Injury Database (iBID) was used to extract demographic and injury information. Data before, during and after COVID-19 lockdown periods was compared. 6919 patients met the inclusion criteria. 1872 (27.1%) of patients required admission. There was a significant reduction in admission rate following covid despite an increase in average TBSA (p<0.01). Most cases were scalds (n=3100, 44.8%) or contact burns (n=2650, 38.3%). The majority of patients were aged under 5 years (n=4529, 65.5%), with a rise in referrals for older children across the study period. There was a noticeable rise in aerosol-related flash burns, cold burns and treadmill- related friction burns during and after the pandemic. This study provides epidemiological data for the development of public health initiatives and adaptation of pediatric burns services. Emerging mechanistic trends and service re-design following the COVID pandemic requires further multi-center evaluation to inform future care.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Sericin based Stretchable and Self-healing Hydrogel Loaded with Psidium guajava L. Extract for Treatment of Burn Wound. 载番石榴提取物丝胶蛋白可拉伸自愈水凝胶的合成及其在烧伤创面治疗中的应用。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-16 DOI: 10.1093/jbcr/irag004
Sidra Arshad, Hafiz Muhammad Tahir, Rida Mahnoor, Aamir Ali, Ayesha Malik, Fariha Munir, Sania Faiz, Fatima Ijaz Cheema, Ayesha Afzal, Farwa Shafique

Burn wounds pose significant challenges due to their susceptibility to microbial invasion and limited effective dressing options. This study aimed to evaluate the wound healing potential of a sericin-based self-healing and stretchable hydrogel loaded with Psidium guajava L. extract against full-thickness burn wounds in mice. The hydrogel was characterized by physicochemical analyses including SEM, FTIR, XRD, viscosity, pH, swelling degree, weight loss, and mechanical strength. In vivo experiments used a Swiss albino mice burn model, where 6 mm full-thickness wounds were induced with a hot metal rod. Hydrogels were applied topically at regular intervals, and wound healing was assessed through wound contraction measurements, healing time, and histological analysis. Hematological parameters and serum biomarkers i.e. pro- and anti-inflammatory cytokines, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), antioxidants (GSH, GPx, CAT, SOD), angiogenic factors (VEGF), and oxidative stress markers (MDA) were also evaluated. Results demonstrated that the hydrogels exhibited high swelling capacity and notable weight loss, suggesting effective absorption of wound exudates and reduced infection risk. Notably, Hydrogel 4 (3% sericin + 3% P. guajava L.) achieved significantly improved wound healing (89.66%) compared to controls (37.16%) by day 15. Histological examination confirmed collagen deposition and hair follicle regeneration, indicative of complete healing. Hematological findings showed increased red blood cell counts and reduced white blood cells, reflecting resolution of inflammation. Serum analyses revealed elevated anti-inflammatory markers (IL-10), TIMPs, and antioxidants (GSH, GPx, CAT, SOD), alongside decreased pro-inflammatory cytokines (IL-6, IL-8, IL-1β, TNF-α), MMPs, angiogenic factor VEGF, and oxidative stress marker MDA. Hydrogel 4 showed a 3.47-fold increase in SOD and a 68% reduction in MDA, underscoring its efficacy in mitigating oxidative stress. In conclusion, the sericin-based hydrogel infused with P. guajava L. exhibited excellent physicochemical and biological properties, promoting effective burn wound healing. Hydrogel 4 demonstrated the most pronounced therapeutic benefits, making it a promising candidate for advanced wound dressing applications.

烧伤创面由于其对微生物入侵的易感性和有限的有效敷料选择而构成重大挑战。本研究旨在评估丝胶蛋白自愈合可拉伸水凝胶负载番石榴提取物对小鼠全层烧伤创面的愈合潜力。通过SEM、FTIR、XRD、粘度、pH、溶胀度、失重、机械强度等理化分析对水凝胶进行表征。体内实验采用瑞士白化病小鼠烧伤模型,用热金属棒诱导6 mm全层创面。定期局部应用水凝胶,通过伤口收缩测量、愈合时间和组织学分析评估伤口愈合情况。血液学参数和血清生物标志物,即促炎和抗炎细胞因子、基质金属蛋白酶(MMPs)、金属蛋白酶组织抑制剂(TIMPs)、抗氧化剂(GSH、GPx、CAT、SOD)、血管生成因子(VEGF)和氧化应激标志物(MDA)也进行了评估。结果表明,水凝胶具有较高的溶胀能力和明显的减重效果,表明水凝胶能有效吸收创面渗出液,降低感染风险。值得注意的是,在第15天,水凝胶4(3%丝胶蛋白+ 3%番石榴)与对照组(37.16%)相比,显著改善了伤口愈合(89.66%)。组织学检查证实胶原沉积和毛囊再生,表明完全愈合。血液学结果显示红细胞计数增加,白细胞减少,反映炎症消退。血清分析显示抗炎标志物(IL-10)、TIMPs和抗氧化剂(GSH、GPx、CAT、SOD)升高,促炎因子(IL-6、IL-8、IL-1β、TNF-α)、MMPs、血管生成因子VEGF和氧化应激标志物MDA降低。水凝胶4的SOD含量增加3.47倍,MDA含量减少68%,表明其具有明显的抗氧化作用。综上所述,番石榴丝胶基水凝胶具有良好的物理化学和生物特性,促进烧伤创面的有效愈合。水凝胶4显示出最明显的治疗效果,使其成为高级伤口敷料应用的有希望的候选者。
{"title":"Synthesis of Sericin based Stretchable and Self-healing Hydrogel Loaded with Psidium guajava L. Extract for Treatment of Burn Wound.","authors":"Sidra Arshad, Hafiz Muhammad Tahir, Rida Mahnoor, Aamir Ali, Ayesha Malik, Fariha Munir, Sania Faiz, Fatima Ijaz Cheema, Ayesha Afzal, Farwa Shafique","doi":"10.1093/jbcr/irag004","DOIUrl":"https://doi.org/10.1093/jbcr/irag004","url":null,"abstract":"<p><p>Burn wounds pose significant challenges due to their susceptibility to microbial invasion and limited effective dressing options. This study aimed to evaluate the wound healing potential of a sericin-based self-healing and stretchable hydrogel loaded with Psidium guajava L. extract against full-thickness burn wounds in mice. The hydrogel was characterized by physicochemical analyses including SEM, FTIR, XRD, viscosity, pH, swelling degree, weight loss, and mechanical strength. In vivo experiments used a Swiss albino mice burn model, where 6 mm full-thickness wounds were induced with a hot metal rod. Hydrogels were applied topically at regular intervals, and wound healing was assessed through wound contraction measurements, healing time, and histological analysis. Hematological parameters and serum biomarkers i.e. pro- and anti-inflammatory cytokines, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), antioxidants (GSH, GPx, CAT, SOD), angiogenic factors (VEGF), and oxidative stress markers (MDA) were also evaluated. Results demonstrated that the hydrogels exhibited high swelling capacity and notable weight loss, suggesting effective absorption of wound exudates and reduced infection risk. Notably, Hydrogel 4 (3% sericin + 3% P. guajava L.) achieved significantly improved wound healing (89.66%) compared to controls (37.16%) by day 15. Histological examination confirmed collagen deposition and hair follicle regeneration, indicative of complete healing. Hematological findings showed increased red blood cell counts and reduced white blood cells, reflecting resolution of inflammation. Serum analyses revealed elevated anti-inflammatory markers (IL-10), TIMPs, and antioxidants (GSH, GPx, CAT, SOD), alongside decreased pro-inflammatory cytokines (IL-6, IL-8, IL-1β, TNF-α), MMPs, angiogenic factor VEGF, and oxidative stress marker MDA. Hydrogel 4 showed a 3.47-fold increase in SOD and a 68% reduction in MDA, underscoring its efficacy in mitigating oxidative stress. In conclusion, the sericin-based hydrogel infused with P. guajava L. exhibited excellent physicochemical and biological properties, promoting effective burn wound healing. Hydrogel 4 demonstrated the most pronounced therapeutic benefits, making it a promising candidate for advanced wound dressing applications.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic and Immunomodulatory Effects of α-Ketoglutarate in Burn Injuries: A Systematic Review. α-酮戊二酸在烧伤中的代谢和免疫调节作用:系统综述。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-08 DOI: 10.1093/jbcr/irag002
Tobias Niederegger, Robert Munzinger, Thomas Schaschinger, Jule Brandt, Leonard Knoedler, Samuel Knoedler, Alen Palackic, Adriana C Panayi, Gabriel Hundeshagen

Severe burns unleash a hyper-catabolic and immunosuppressive state that erodes lean tissue and delays repair. Alpha-ketoglutarate (α-KG), usually delivered enterally as the dipeptide ornithine α-ketoglutarate, feeds the tricarboxylic-acid cycle, donates nitrogen for amino-acid synthesis, and modulates collagen formation and immunity. We systematically appraised the biological mechanisms, delivery strategies, and clinical outcomes associated with α-KG/OKG in burn care to clarify its therapeutic value and translational readiness. A PRISMA-2020-compliant search of PubMed, EMBASE, Web of Science, Cochrane, and Google Scholar up to May 2025 identified clinical, in-vivo, and relevant in-vitro studies linking α-KG or OKG with thermal injury. Study quality was assessed using the Newcastle-Ottawa Scale, SYRCLE Risk-of-Bias tool, and Oxford Levels of Evidence. Fifteen studies published between 1984 and 2024 met inclusion criteria, including clinical, animal, and mechanistic work, most conducted in France. Across studies, OKG supplementation replenished glutamine and arginine pools, improved nitrogen balance, preserved muscle mass, and promoted wound healing through enhanced collagen synthesis and immune modulation. Clinical data confirmed improved nitrogen retention, reduced muscle breakdown, and faster wound closure. Preclinical studies further showed that α-KG preconditioning enhances stem cell-driven regeneration and vascularization. Additional effects, such as improved glucose tolerance and hepatic enzyme preservation, suggest some benefits occur independently of glutamine pathways. This review highlights α-KG and OKG as promising adjuncts to enhance metabolic recovery, wound repair, and immune competence after burns. Evidence supports improved nitrogen balance and healing, but findings remain limited by heterogeneity and small cohorts, warranting renewed and well-powered studies.

严重的烧伤释放出高分解代谢和免疫抑制状态,侵蚀瘦组织并延迟修复。α-酮戊二酸(α-KG)通常以鸟氨酸二肽α-酮戊二酸的形式肠内给药,为三羧酸循环提供养分,为氨基酸合成提供氮,调节胶原形成和免疫。我们系统地评估了α-KG/OKG在烧伤护理中的生物学机制、传递策略和临床结果,以阐明其治疗价值和转化准备。截至2025年5月,PubMed、EMBASE、Web of Science、Cochrane和谷歌Scholar的一项符合prisma -2020标准的搜索发现,临床、体内和相关的体外研究将α-KG或OKG与热损伤联系起来。使用纽卡斯尔-渥太华量表、sycle偏倚风险工具和牛津证据水平评估研究质量。1984年至2024年间发表的15项研究符合纳入标准,包括临床、动物和机械工作,其中大多数在法国进行。研究表明,补充OKG可以补充谷氨酰胺和精氨酸,改善氮平衡,保持肌肉质量,并通过增强胶原合成和免疫调节促进伤口愈合。临床数据证实氮潴留改善,肌肉分解减少,伤口愈合更快。临床前研究进一步表明,α-KG预处理可促进干细胞驱动的再生和血管形成。其他作用,如改善葡萄糖耐量和肝酶保存,表明一些益处独立于谷氨酰胺途径发生。这篇综述强调α-KG和OKG是有希望的辅助剂,可以增强烧伤后的代谢恢复、伤口修复和免疫能力。证据支持改善氮平衡和愈合,但研究结果仍然受到异质性和小队列的限制,需要更新和更有力的研究。
{"title":"Metabolic and Immunomodulatory Effects of α-Ketoglutarate in Burn Injuries: A Systematic Review.","authors":"Tobias Niederegger, Robert Munzinger, Thomas Schaschinger, Jule Brandt, Leonard Knoedler, Samuel Knoedler, Alen Palackic, Adriana C Panayi, Gabriel Hundeshagen","doi":"10.1093/jbcr/irag002","DOIUrl":"https://doi.org/10.1093/jbcr/irag002","url":null,"abstract":"<p><p>Severe burns unleash a hyper-catabolic and immunosuppressive state that erodes lean tissue and delays repair. Alpha-ketoglutarate (α-KG), usually delivered enterally as the dipeptide ornithine α-ketoglutarate, feeds the tricarboxylic-acid cycle, donates nitrogen for amino-acid synthesis, and modulates collagen formation and immunity. We systematically appraised the biological mechanisms, delivery strategies, and clinical outcomes associated with α-KG/OKG in burn care to clarify its therapeutic value and translational readiness. A PRISMA-2020-compliant search of PubMed, EMBASE, Web of Science, Cochrane, and Google Scholar up to May 2025 identified clinical, in-vivo, and relevant in-vitro studies linking α-KG or OKG with thermal injury. Study quality was assessed using the Newcastle-Ottawa Scale, SYRCLE Risk-of-Bias tool, and Oxford Levels of Evidence. Fifteen studies published between 1984 and 2024 met inclusion criteria, including clinical, animal, and mechanistic work, most conducted in France. Across studies, OKG supplementation replenished glutamine and arginine pools, improved nitrogen balance, preserved muscle mass, and promoted wound healing through enhanced collagen synthesis and immune modulation. Clinical data confirmed improved nitrogen retention, reduced muscle breakdown, and faster wound closure. Preclinical studies further showed that α-KG preconditioning enhances stem cell-driven regeneration and vascularization. Additional effects, such as improved glucose tolerance and hepatic enzyme preservation, suggest some benefits occur independently of glutamine pathways. This review highlights α-KG and OKG as promising adjuncts to enhance metabolic recovery, wound repair, and immune competence after burns. Evidence supports improved nitrogen balance and healing, but findings remain limited by heterogeneity and small cohorts, warranting renewed and well-powered studies.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting the Enduring Principles of Plastic Surgery. 重新审视整形手术经久不衰的原则。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-06 DOI: 10.1093/jbcr/iraf180
Alan D Rogers
{"title":"Revisiting the Enduring Principles of Plastic Surgery.","authors":"Alan D Rogers","doi":"10.1093/jbcr/iraf180","DOIUrl":"10.1093/jbcr/iraf180","url":null,"abstract":"","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":"414-415"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nares Swabs in Burn-Injured Patients. 耐甲氧西林金黄色葡萄球菌聚合酶链反应鼻拭子在烧伤患者中的临床应用。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-06 DOI: 10.1093/jbcr/iraf120
Jade Montgomery, Rachel Burgoon, Aaron Hamby, Melanie Smith Condeni

Methicillin-resistant Staphylococcus aureus (MRSA) is a common pathogen in burn-injured patients. Many studies have evaluated the overall utility of MRSA nares polymerase chain reaction (PCR) swabs for antimicrobial stewardship; however, there is a paucity of data in burns. This study evaluated the clinical utility of MRSA PCR in burn-injured patients at an academic medical center. This retrospective, single-center chart review included admitted adult burn-injured patients from July 2020 to June 2024. The primary objective was to determine the overall negative predictive value (NPV) of MRSA PCR in patients with burn injuries for suspected MRSA infections. Secondary objectives included determining the sensitivity, specificity, NPV, and positive predictive value (PPV) of MRSA PCR for specific culture types. There were 89 patients, and 289 cultures were included. The overall prevalence of MRSA positive cultures was 13.4% for the study period. For the primary outcome, the NPV of MRSA PCR was 98.3% (95% confidence interval, 95.5%-99.5%). For the whole cohort the PPV was 22.5%, sensitivity was 73.4%, and specificity was 86.1%. The total cost of vancomycin therapy (doses and levels) was US $37 935.75, which was estimated using average wholesale price. A cost avoidance of US $378.15 per patient was estimated for patients not meeting criteria for vancomycin therapy. Overall, this study found a high NPV for MRSA PCR in burn-injured patients with suspected infections. In addition, MRSA PCR may be used along with other clinical markers to decrease the use of antimicrobials targeting MRSA, which may help decrease the cost of therapy.

耐甲氧西林金黄色葡萄球菌(MRSA)是烧伤患者常见的病原菌。许多研究已经评估了MRSA纳米聚合酶链反应(PCR)拭子在抗菌药物管理中的总体效用;然而,关于烧伤的数据缺乏。本研究评估了MRSA PCR在某学术医疗中心烧伤患者中的临床应用。这项回顾性的单中心图表回顾纳入了2020年7月至2024年6月住院的成人烧伤患者。主要目的是确定MRSA PCR对烧伤患者疑似MRSA感染的总体阴性预测值(NPV)。次要目的包括确定MRSA PCR对特定培养类型的敏感性、特异性、NPV和阳性预测值(PPV)。89例患者,289例培养。在研究期间,MRSA阳性培养的总体流行率为13.4%。对于主要结局,MRSA PCR的NPV为98.3%[95%可信区间95.5-99.5%]。整个队列的PPV为22.5%,敏感性为73.4%,特异性为86.1%。万古霉素治疗的总费用(剂量和水平)为37,935.75美元,这是使用平均批发价格估计的。对于不符合万古霉素治疗标准的患者,估计每位患者可避免378.15美元的费用。总体而言,本研究发现MRSA PCR对烧伤患者感染的NPV较高。此外,MRSA PCR可以与其他临床标记一起使用,以减少针对MRSA的抗菌剂的使用,这可能有助于降低治疗成本。
{"title":"Clinical Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nares Swabs in Burn-Injured Patients.","authors":"Jade Montgomery, Rachel Burgoon, Aaron Hamby, Melanie Smith Condeni","doi":"10.1093/jbcr/iraf120","DOIUrl":"10.1093/jbcr/iraf120","url":null,"abstract":"<p><p>Methicillin-resistant Staphylococcus aureus (MRSA) is a common pathogen in burn-injured patients. Many studies have evaluated the overall utility of MRSA nares polymerase chain reaction (PCR) swabs for antimicrobial stewardship; however, there is a paucity of data in burns. This study evaluated the clinical utility of MRSA PCR in burn-injured patients at an academic medical center. This retrospective, single-center chart review included admitted adult burn-injured patients from July 2020 to June 2024. The primary objective was to determine the overall negative predictive value (NPV) of MRSA PCR in patients with burn injuries for suspected MRSA infections. Secondary objectives included determining the sensitivity, specificity, NPV, and positive predictive value (PPV) of MRSA PCR for specific culture types. There were 89 patients, and 289 cultures were included. The overall prevalence of MRSA positive cultures was 13.4% for the study period. For the primary outcome, the NPV of MRSA PCR was 98.3% (95% confidence interval, 95.5%-99.5%). For the whole cohort the PPV was 22.5%, sensitivity was 73.4%, and specificity was 86.1%. The total cost of vancomycin therapy (doses and levels) was US $37 935.75, which was estimated using average wholesale price. A cost avoidance of US $378.15 per patient was estimated for patients not meeting criteria for vancomycin therapy. Overall, this study found a high NPV for MRSA PCR in burn-injured patients with suspected infections. In addition, MRSA PCR may be used along with other clinical markers to decrease the use of antimicrobials targeting MRSA, which may help decrease the cost of therapy.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":"160-166"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144560243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diverting Ostomy Practices in Burn Surgeons Treating Full-Thickness Perianal Injuries. 转移造口术治疗全层肛周损伤。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-06 DOI: 10.1093/jbcr/iraf141
Annie Cate Schmidt, Anne Seyferth, Michelle Hughes, William B Hughes

Burns to the perianal region pose specific challenges in management due to the complex structure of the surrounding tissue, bacterial contamination, and repetitive stress. Fecal diversion via diverting ostomy may be elected in these injuries because of its potential to enhance wound healing and skin graft adherence; however, its use introduces alternative risks such as prolonged ileus, fistula, leakage, and failure of reversal. This study aimed to determine the perspectives of burn surgeons regarding the use of diverting ostomy for perianal burn injuries. We conducted a survey of 12 physicians who are burn center directors in the Northeast Region of the American Burn Association regarding their practices for patients with full-thickness perianal burn injuries requiring a skin graft. Response rate was 11/12 (92%). Six individuals (54.5%) reported "Never (0%)" to performing a diverting ostomy in this context; the remaining 5 individuals responded "Rarely (<10%)." Reasons stated for performing a diverting ostomy in the "Rarely" group included cases where the patient suffered an intra-anal or anorectal injury. These results were summarized with a relevant review of the literature and experience in our clinical practice. Our findings indicate that diverting ostomy is a relatively uncommon practice for burn surgeons treating full-thickness buttocks injuries. With appropriate wound care and critical care management, good outcomes can be obtained without the need for diverting ostomy. Non-surgical alternatives to fecal diversion are commonly used by burn specialists and should be considered in perianal burn injuries.

由于周围组织的复杂结构、细菌污染和重复应激,肛周烧伤在管理上提出了具体的挑战。在这些损伤中,可以选择通过转移造口进行粪便转移,因为它有可能促进伤口愈合和皮肤移植的粘附性;然而,它的使用带来了其他风险,如延长肠梗阻,瘘,渗漏和逆转失败。本研究的目的是确定烧伤外科医生在肛管周围烧伤中使用转向造口术的观点。我们对美国烧伤协会(ABA)东北地区烧伤中心主任的12名医生进行了一项调查,调查内容是关于他们对需要植皮的全层肛周烧伤患者的治疗情况。有效率为11/12(92%)。6人(54.5%)报告在这种情况下“从未(0%)”进行过转移造口术;剩下的5个人回答“很少(
{"title":"Diverting Ostomy Practices in Burn Surgeons Treating Full-Thickness Perianal Injuries.","authors":"Annie Cate Schmidt, Anne Seyferth, Michelle Hughes, William B Hughes","doi":"10.1093/jbcr/iraf141","DOIUrl":"10.1093/jbcr/iraf141","url":null,"abstract":"<p><p>Burns to the perianal region pose specific challenges in management due to the complex structure of the surrounding tissue, bacterial contamination, and repetitive stress. Fecal diversion via diverting ostomy may be elected in these injuries because of its potential to enhance wound healing and skin graft adherence; however, its use introduces alternative risks such as prolonged ileus, fistula, leakage, and failure of reversal. This study aimed to determine the perspectives of burn surgeons regarding the use of diverting ostomy for perianal burn injuries. We conducted a survey of 12 physicians who are burn center directors in the Northeast Region of the American Burn Association regarding their practices for patients with full-thickness perianal burn injuries requiring a skin graft. Response rate was 11/12 (92%). Six individuals (54.5%) reported \"Never (0%)\" to performing a diverting ostomy in this context; the remaining 5 individuals responded \"Rarely (<10%).\" Reasons stated for performing a diverting ostomy in the \"Rarely\" group included cases where the patient suffered an intra-anal or anorectal injury. These results were summarized with a relevant review of the literature and experience in our clinical practice. Our findings indicate that diverting ostomy is a relatively uncommon practice for burn surgeons treating full-thickness buttocks injuries. With appropriate wound care and critical care management, good outcomes can be obtained without the need for diverting ostomy. Non-surgical alternatives to fecal diversion are commonly used by burn specialists and should be considered in perianal burn injuries.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":"231-235"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144637132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary Analysis of American Burn Association National Burn Repository to Investigate Impact of Cellular, Acellular, and Matrix-Based Products Use in Burn Wound Management. 美国烧伤协会(ABA)国家烧伤库调查细胞、非细胞和基质产品(营地)在烧伤创面管理中的影响的初步分析。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-06 DOI: 10.1093/jbcr/iraf147
Roselle E Crombie, Claire E Witherel
<p><p>Cellular, acellular, and matrix-like products (CAMPs), also known as skin, dermal, or tissue substitutes, have been used to manage thermal injuries for over 20 years with over 75 commercially available products today. Despite demonstrating long-term safety and efficacy, the use of CAMPs remains controversial in the burn community in terms of clinical benefit, economics, clinical algorithm, and lack of standardization in coding or categorization of specific products. Most clinical studies regarding CAMP use are product-specific prospective or retrospective studies comparing against split-thickness skin grafts alone, but very few have investigated the impact of product-agnostic CAMP use in burn care using the National Burn Repository (NBR). The goal of this study was to document CAMP use in burn management from 2016 to 2021 and provide a preliminary analysis of how CAMP use, including non-autologous and synthetic "tissue substitutes" categorization, may impact patient care compared to not using a CAMP at all. National Burn Repository data from 2008 to 2021 were analyzed (n = 388 775 patients). Surviving patients treated with complete procedure code data treated "tissue substitute" (synthetic or non-autologous) during their care were identified via ICD-10 procedure codes (n = 29 919 patients, 2016-2021 data). Aggregated metrics included patient demographic information (age, sex, race, and burn degree) and case measurements (length of stay [LOS], total body surface area [TBSA: second, third, and combined], complications, resource utilization, number of procedures, and number of excisional debridements). Additional analyses included determining the percentage of second- and third-degree burns (normalizing against total TBSA to obtain patient cohorts that are defined as "Predominantly second" and "Predominantly third") and normalizing patients' LOS per TBSA. An additional surviving patient cohort that was not treated with a CAMP (n = 46 589 patients) was identified to directly compare the case measurements listed above. The general frequency of patients treated with CAMPs has increased from 2016 to 2020. However, the number of patients treated with a CAMP, except patients aged 70 years or older, decreased from 2020 to 2021. Patients with predominantly second-degree burns were treated with CAMPs more often than those with predominantly third-degree burns. CAMP use, regardless of burn depth or normalization against TBSA, was associated with higher LOS/TBSA and more procedures overall, but also associated with a significantly lower rate of skin, wound, or graft-loss-related complications and fewer resources utilized overall compared to patients not treated with a CAMP. Cellular, acellular, and matrix-like product/Skin substitutes separated into non-autologous and synthetic tissue substitutes categories demonstrated significant differences, but should be considered preliminary due to limitations in data collection. This study illustrates the first an
细胞,脱细胞和基质样产品(营地),也被称为皮肤,真皮或组织替代品,已用于管理热损伤超过20年,今天有超过75种市售产品。尽管显示出长期的安全性和有效性,但在烧伤社区中,camp的使用在临床获益、经济、临床算法以及缺乏特定产品编码或分类的标准化方面仍然存在争议。大多数关于CAMP使用的临床研究都是针对特定产品的前瞻性或回顾性研究,与单独的裂厚皮肤移植进行比较,但很少有研究使用国家烧伤存储库调查与产品无关的CAMP在烧伤护理中的影响。本研究的目的是记录2016-2021年CAMP在烧伤管理中的使用情况,并初步分析CAMP的使用,包括非自体和合成“组织替代品”分类,与完全不使用CAMP相比,可能会如何影响患者护理。方法:分析2008-2021年国家烧伤数据库数据(n = 388 775例患者)。通过ICD-10程序代码(n = 29919例患者,2016-2021年数据)识别在治疗期间接受“组织替代品”(合成或非自体)治疗的完整程序代码数据的存活患者。汇总指标包括患者人口统计信息(年龄、性别、种族、烧伤程度)和病例测量(住院时间(LOS)、全身表面积(TBSA)(第二次、第三次和联合)、并发症、资源利用、手术次数和切除清创次数)。其他分析包括确定2度和3度烧伤的百分比(根据总TBSA进行正常化,以获得定义为“主要是2度”和“主要是3度”的患者队列)和每TBSA患者LOS的正常化。另一个未接受CAMP治疗的存活患者队列(n = 46 589例患者)被确定为直接比较上述病例测量值。结果:2016 - 2020年,camp治疗患者的总频次有所增加。然而,从2020年到2021年,除70岁及以上的患者外,接受CAMP治疗的患者数量有所减少。以二度烧伤为主的患者比以三度烧伤为主的患者更常使用camp治疗。与未使用CAMP治疗的患者相比,无论烧伤深度或TBSA的正常化程度如何,CAMP的使用与更高的LOS/TBSA和更多的手术有关,但也与皮肤、伤口或移植物丢失相关并发症的发生率显著降低有关,并且总体上使用的资源较少。CAMP/皮肤代用品分为非自体和合成组织代用品类别,显示出显著差异,但由于数据收集的限制,应视为初步研究。结论:本研究首次分析了ABA国家烧伤库,以调查烧伤的具体护理算法(CAMP使用),包括高TBSA烧伤。这开始回顾性地阐明与一种或另一种护理途径相关的结果,并最终强调了烧伤护理方法普遍缺乏标准化,NBR中的文档和编码。未来的分析将需要进一步增加这些结果的特异性和有效性,并了解CAMP用于烧伤的健康经济影响。
{"title":"Preliminary Analysis of American Burn Association National Burn Repository to Investigate Impact of Cellular, Acellular, and Matrix-Based Products Use in Burn Wound Management.","authors":"Roselle E Crombie, Claire E Witherel","doi":"10.1093/jbcr/iraf147","DOIUrl":"10.1093/jbcr/iraf147","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Cellular, acellular, and matrix-like products (CAMPs), also known as skin, dermal, or tissue substitutes, have been used to manage thermal injuries for over 20 years with over 75 commercially available products today. Despite demonstrating long-term safety and efficacy, the use of CAMPs remains controversial in the burn community in terms of clinical benefit, economics, clinical algorithm, and lack of standardization in coding or categorization of specific products. Most clinical studies regarding CAMP use are product-specific prospective or retrospective studies comparing against split-thickness skin grafts alone, but very few have investigated the impact of product-agnostic CAMP use in burn care using the National Burn Repository (NBR). The goal of this study was to document CAMP use in burn management from 2016 to 2021 and provide a preliminary analysis of how CAMP use, including non-autologous and synthetic \"tissue substitutes\" categorization, may impact patient care compared to not using a CAMP at all. National Burn Repository data from 2008 to 2021 were analyzed (n = 388 775 patients). Surviving patients treated with complete procedure code data treated \"tissue substitute\" (synthetic or non-autologous) during their care were identified via ICD-10 procedure codes (n = 29 919 patients, 2016-2021 data). Aggregated metrics included patient demographic information (age, sex, race, and burn degree) and case measurements (length of stay [LOS], total body surface area [TBSA: second, third, and combined], complications, resource utilization, number of procedures, and number of excisional debridements). Additional analyses included determining the percentage of second- and third-degree burns (normalizing against total TBSA to obtain patient cohorts that are defined as \"Predominantly second\" and \"Predominantly third\") and normalizing patients' LOS per TBSA. An additional surviving patient cohort that was not treated with a CAMP (n = 46 589 patients) was identified to directly compare the case measurements listed above. The general frequency of patients treated with CAMPs has increased from 2016 to 2020. However, the number of patients treated with a CAMP, except patients aged 70 years or older, decreased from 2020 to 2021. Patients with predominantly second-degree burns were treated with CAMPs more often than those with predominantly third-degree burns. CAMP use, regardless of burn depth or normalization against TBSA, was associated with higher LOS/TBSA and more procedures overall, but also associated with a significantly lower rate of skin, wound, or graft-loss-related complications and fewer resources utilized overall compared to patients not treated with a CAMP. Cellular, acellular, and matrix-like product/Skin substitutes separated into non-autologous and synthetic tissue substitutes categories demonstrated significant differences, but should be considered preliminary due to limitations in data collection. This study illustrates the first an","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":"85-95"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revascularize or Amputate? Underrated Arterial Damage in High-Voltage Electrocution: A Literature-Informed Clinical Perspective. 血运重建还是截肢?高压电刑中被低估的动脉损伤:一个文献知情的临床观点。
IF 1.8 4区 医学 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-06 DOI: 10.1093/jbcr/iraf182
Paolo Marchica, Isidoro Musmarra, Francesco Ciancio, Dario Melita, Adelina Vena, Rosario Ranno, Giuseppe A G Lombardo

High-voltage electrocution injuries can result in extensive, multisystem tissue damage, including vascular injuries. The decision between revascularization and early amputation remains challenging, especially given the risks of hemorrhage, infection, and repair failure. A comprehensive literature review was performed using PubMed, Scopus, and Cochrane databases with predefined MeSH terms and keywords related to electrocution and arterial injury. Nineteen relevant human studies were selected after screening. In addition, we present a case of high-voltage upper limb injury in which an arterial interposition graft using the deep inferior epigastric artery (DIEA) was performed in an attempt to maintain hand perfusion. Most published reports describe venous grafts-the most commonly used option-or flow-through flaps as reconstructive options. To date, no previous cases have reported the use of arterial grafts in this context. Arterial injuries may present acutely or subacutely, and a variety of repair techniques have been described, without clear evidence favoring one approach over another. In our case, despite technically successful placement of a DIEA arterial graft following radial artery rupture, early thrombosis and distal ischemia occurred, ultimately resulting in limb loss. Vascular injury from electrocution is often more extensive than macroscopically evident. Reconstructive attempts should be considered only in stable patients, especially when preserving the dominant limb in young individuals. Although arterial grafts offer structural advantages, they may not overcome the systemic and local damage induced by electrocution. Further research is needed to define clearer guidelines for vascular repair versus amputation in these complex scenarios.

高压触电损伤可导致广泛的多系统组织损伤,包括血管损伤。在血运重建术和早期截肢之间的决定仍然具有挑战性,特别是考虑到出血、感染和修复失败的风险。我们使用PubMed、Scopus和Cochrane数据库进行了全面的文献综述,其中包含与触电和动脉损伤相关的预定义MeSH术语和关键词。筛选后选择了19项相关的人体研究。此外,我们报告了一例高压上肢损伤,其中使用腹下深动脉(DIEA)进行动脉间置移植物,试图维持手部灌注。大多数已发表的报告描述了最常用的静脉移植物或流过皮瓣作为重建的选择。到目前为止,还没有先例报道在这种情况下使用动脉移植。动脉损伤可表现为急性或亚急性,各种修复技术已被描述,但没有明确的证据支持一种方法优于另一种方法。在我们的病例中,尽管技术上成功地在桡动脉破裂后放置了DIEA动脉移植物,但早期血栓形成和远端缺血发生,最终导致肢体丧失。电刑引起的血管损伤通常比宏观上明显的更广泛。只有在病情稳定的患者中才应考虑重建尝试,特别是在年轻人保留主肢时。尽管动脉移植物具有结构上的优势,但它们可能无法克服电刑引起的全身和局部损伤。在这些复杂的情况下,需要进一步的研究来确定更明确的血管修复和截肢的指导方针。
{"title":"Revascularize or Amputate? Underrated Arterial Damage in High-Voltage Electrocution: A Literature-Informed Clinical Perspective.","authors":"Paolo Marchica, Isidoro Musmarra, Francesco Ciancio, Dario Melita, Adelina Vena, Rosario Ranno, Giuseppe A G Lombardo","doi":"10.1093/jbcr/iraf182","DOIUrl":"10.1093/jbcr/iraf182","url":null,"abstract":"<p><p>High-voltage electrocution injuries can result in extensive, multisystem tissue damage, including vascular injuries. The decision between revascularization and early amputation remains challenging, especially given the risks of hemorrhage, infection, and repair failure. A comprehensive literature review was performed using PubMed, Scopus, and Cochrane databases with predefined MeSH terms and keywords related to electrocution and arterial injury. Nineteen relevant human studies were selected after screening. In addition, we present a case of high-voltage upper limb injury in which an arterial interposition graft using the deep inferior epigastric artery (DIEA) was performed in an attempt to maintain hand perfusion. Most published reports describe venous grafts-the most commonly used option-or flow-through flaps as reconstructive options. To date, no previous cases have reported the use of arterial grafts in this context. Arterial injuries may present acutely or subacutely, and a variety of repair techniques have been described, without clear evidence favoring one approach over another. In our case, despite technically successful placement of a DIEA arterial graft following radial artery rupture, early thrombosis and distal ischemia occurred, ultimately resulting in limb loss. Vascular injury from electrocution is often more extensive than macroscopically evident. Reconstructive attempts should be considered only in stable patients, especially when preserving the dominant limb in young individuals. Although arterial grafts offer structural advantages, they may not overcome the systemic and local damage induced by electrocution. Further research is needed to define clearer guidelines for vascular repair versus amputation in these complex scenarios.</p>","PeriodicalId":15205,"journal":{"name":"Journal of Burn Care & Research","volume":" ","pages":"381-389"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Burn Care & Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1